Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wild

Showing results (601-610 of 738) with videos related to

Pageof 74
Sort By:
The Lancet. Neurology|June 12, 2017
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisLauren M Byrne, Filipe B Rodrigues, Kaj Blennow, et al.
British Journal of Clinical Pharmacology|November 25, 2025
Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patientsYumi Yamamoto, Hanna E Silber Baumann, Marcus Björnsson, et al.
Archives of Disease in Childhood|July 28, 2009
Falling asleep: the determinants of sleep latencyG M Nixon, J M D Thompson, D Y Han, et al.
Archives of Disease in Childhood|September 15, 2007
Risk factors for obesity in 7-year-old European children: the Auckland Birthweight Collaborative StudyNikki J Blair, John M D Thompson, Peter N Black, et al.
EMBO Molecular Medicine|June 9, 2012
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humansPeter J Wild, Kristian Ikenberg, Thomas J Fuchs, et al.
Blood Cells, Molecules & Diseases|May 10, 2003
Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcomeJulia L Clarke, Tom J Vulliamy, David Roper, et al.
Brain : a Journal of Neurology|September 6, 2008
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's diseaseValerio Leoni, Caterina Mariotti, Sarah J Tabrizi, et al.
Journal of Cancer Research and Clinical Oncology|May 12, 2025
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patientsMaximilian N Kinzler, Eric Metzger, Rebecca Schulz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2024
Huntington's disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing explorationCarolin Anna Maria Koriath, Fernando Guntoro, Penelope Norsworthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancerEdgar Dahl, Glen Kristiansen, Kathrin Gottlob, et al.
Pageof 74

Showing results (601-610 of 738) with videos related to

Sort By:
Pageof 74
The Lancet. Neurology|June 12, 2017
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisLauren M Byrne, Filipe B Rodrigues, Kaj Blennow, et al.
British Journal of Clinical Pharmacology|November 25, 2025
Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patientsYumi Yamamoto, Hanna E Silber Baumann, Marcus Björnsson, et al.
Archives of Disease in Childhood|July 28, 2009
Falling asleep: the determinants of sleep latencyG M Nixon, J M D Thompson, D Y Han, et al.
Archives of Disease in Childhood|September 15, 2007
Risk factors for obesity in 7-year-old European children: the Auckland Birthweight Collaborative StudyNikki J Blair, John M D Thompson, Peter N Black, et al.
EMBO Molecular Medicine|June 9, 2012
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humansPeter J Wild, Kristian Ikenberg, Thomas J Fuchs, et al.
Blood Cells, Molecules & Diseases|May 10, 2003
Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcomeJulia L Clarke, Tom J Vulliamy, David Roper, et al.
Brain : a Journal of Neurology|September 6, 2008
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's diseaseValerio Leoni, Caterina Mariotti, Sarah J Tabrizi, et al.
Journal of Cancer Research and Clinical Oncology|May 12, 2025
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patientsMaximilian N Kinzler, Eric Metzger, Rebecca Schulz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2024
Huntington's disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing explorationCarolin Anna Maria Koriath, Fernando Guntoro, Penelope Norsworthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancerEdgar Dahl, Glen Kristiansen, Kathrin Gottlob, et al.
Pageof 74